Legionella andPneumocystis pneumonias in asthmatic children on high doses of systemic steroids
- 1 September 1994
- journal article
- case report
- Published by Wiley in Pediatric Pulmonology
- Vol. 18 (3) , 135-138
- https://doi.org/10.1002/ppul.1950180303
Abstract
Asthma is increasingly treated as an inflammatory disease with inhaled and/or systemic corticosteroids. We report 3 cases of unusual pneumonias associated with high doses of oral steroids. Two patients contracted Legionella pneumonia and one patient contracted Pneumocystis carinii pneumonia. With increasing usage, it is important for physicians to be aware of the possible infectious complications of high dose steroids. This report highlights the risk of corticosteroid treatment in asthma in predisposing to opportunistic infections that have not heretofore been readily associated with asthma.Pediatr Pulmonol. 1994;18:135–138.Keywords
This publication has 14 references indexed in Scilit:
- Fatal pneumocystis pneumonia in asthmatic patient treated with methotrexateThe Lancet, 1992
- Pneumocystis carinii Pneumonia Due to CorticosteroidsSouthern Medical Journal, 1992
- Fatal varicella in steroid-dependent asthmaJournal of Allergy and Clinical Immunology, 1988
- Adverse Side Effects of CorticosteroidsSeminars in Respiratory and Critical Care Medicine, 1987
- Therapeutic concentrations of glucocorticoids suppress the antimicrobial activity of human macrophages without impairing their responsiveness to gamma interferon.Journal of Clinical Investigation, 1985
- Opportunistic Infections in Endogenous Cushing's SyndromeAnnals of Internal Medicine, 1984
- Interaction between the legionnaires' disease bacterium (Legionella pneumophila) and human alveolar macrophages. Influence of antibody, lymphokines, and hydrocortisone.Journal of Clinical Investigation, 1984
- The Compromised Host and Legionnaires' DiseaseAnnals of Internal Medicine, 1979
- Biochemical actions of glucocorticoids on macrophages in culture. Specific inhibition of elastase, collagenase, and plasminogen activator secretion and effects on other metabolic functions.The Journal of Experimental Medicine, 1978
- The Compromised Host and InfectionJAMA, 1967